M

Monte Rosa Therapeutics Inc
NASDAQ:GLUE

Watchlist Manager
Monte Rosa Therapeutics Inc
NASDAQ:GLUE
Watchlist
Price: 6.78 USD 0.89% Market Closed
Market Cap: 416.6m USD
Have any thoughts about
Monte Rosa Therapeutics Inc?
Write Note

Wall Street
Price Targets

GLUE Price Targets Summary
Monte Rosa Therapeutics Inc

Wall Street analysts forecast GLUE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLUE is 16.32 USD with a low forecast of 11.11 USD and a high forecast of 21 USD.

Lowest
Price Target
11.11 USD
64% Upside
Average
Price Target
16.32 USD
141% Upside
Highest
Price Target
21 USD
210% Upside
Monte Rosa Therapeutics Inc Competitors:
Price Targets
2616
CStone Pharmaceuticals
5% Downside
CMPX
Compass Therapeutics Inc.
232% Upside
BTAI
BioXcel Therapeutics Inc
56% Upside
MBX
Microbix Biosystems Inc
48% Upside
NTRA
Natera Inc
10% Upside
VTVT
vTv Therapeutics Inc
64% Upside
SNDX
Syndax Pharmaceuticals Inc
147% Upside
ZEAL
Zealand Pharma A/S
35% Upside

Revenue
Forecast

Revenue Estimate
Monte Rosa Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Monte Rosa Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Monte Rosa Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GLUE's stock price target?
Price Target
16.32 USD

According to Wall Street analysts, the average 1-year price target for GLUE is 16.32 USD with a low forecast of 11.11 USD and a high forecast of 21 USD.

Back to Top